Primary tumour response on breast MRI as a predictor of axillary pathologic response in breast cancer patients treated with neoadjuvant chemotherapy - Quiz - MDSpire

Primary tumour response on breast MRI as a predictor of axillary pathologic response in breast cancer patients treated with neoadjuvant chemotherapy

  • By

  • Florien J. G. van Amstel

  • Rik G. M. van Mierlo

  • Patty J. Nelemans

  • Sanne M. E. Engelen

  • Janneke Houwers

  • Loes F. S. Kooreman

  • Vivianne C. G. Tjan-Heijnen

  • Sabine Siesling

  • Marjolein L. Smidt

  • Thiemo J. A. van Nijnatten

  • December 23, 2025

  • 0 min

Share

Original Source(s)

Primary tumour response on breast MRI as a predictor of axillary pathologic response in breast cancer patients treated with neoadjuvant chemotherapy

  • by Florien J. G. van Amstel, Rik G. M. van Mierlo, Patty J. Nelemans, Sanne M. E. Engelen, Janneke Houwers, Loes F. S. Kooreman, Vivianne C. G. Tjan-Heijnen, Sabine Siesling, Marjolein L. Smidt, Thiemo J. A. van Nijnatten

  • December 23, 2025

Related Content

Performance across different versions of an artificial intelligence model for screen-reading of mammograms

Evaluating Ultrasound as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Systematic Review and Meta-Analysis

The Impact of Physical Activity Levels on Sexual Function in Breast Cancer Survivors: An Integrative Review

Sexual dysfunction is a lasting effect of treatment and can impact the quality of life of breast cancer survivors. This review examined the impact of different levels (none/low, moderate, and high) of physical activity on sexual outcomes in breast cancer survivors.